Medgenics (MDGN) Narrows Q3 Loss
Tweet
Share
E-mailGet Alerts mdgn Hot Sheet
Join SI Premium – FREE
Medgenics (NYSE: MDGN) reported Q3 EPS of ($0.21), versus ($0.33) reported last year.
For earnings history and earnings-related data on Medgenics (MDGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens launches transportation coverage, names FedEx a top large-cap pick
- UBS Upgrades Schaeffler AG (SHA:GR) (SFFLY) to Neutral
- ASML Holding NV (ASML:NA) (ASML) PT Raised to EUR2,150 at Deutsche Bank
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
